Korean sunscreen for rosacea: a 2021 review found six original studies on sunscreen in rosacea

Korean Sunscreen for Rosacea: A 2021 Review Found 6 Studies

Search for a Korean sunscreen for rosacea and you’ll get product lists. Centella, panthenol, madecassoside, mineral filters, and a ranked row of bottles. What those pages tend to leave out is how much research is standing behind the advice. One review went and counted, and the number is small enough to fit in a headline. It found six.

The short version: The link between ultraviolet light and rosacea is well described. A 2021 narrative review in the Journal of Cosmetic Dermatology says UV light is implicated in inflammation, new vessel growth, telangiectasia and fibrosis, and that it may even start the condition off.[1] The part that rarely travels with the advice is the next sentence. Searching PubMed up to November 2020, that review reports it found six original articles on what sunscreen actually does in rosacea, and calls the photoprotection literature here scarce.[1] One of those six enrolled 44 people, ran with no control group, and had every author on the payroll of the manufacturer whose product was tested.[2] None of that means skip sun protection. It means confident product rankings are running well ahead of what has been measured.

The UV part is not the shaky part

Start with what the literature does support, because it’s the stronger half.

The 2021 review describes the pathophysiology of rosacea as not completely understood, and multi-factorial, listing “genetics, ultraviolet (UV) light, microorganisms, impaired skin barrier, neuronal and vascular dysfunction, and immune system disruption” as interacting pieces.[1] On UV specifically it reports that radiation “was reported to induce pro-inflammatory, pro-angiogenic, and pro-fibrotic responses.”[1] Its conclusion places UV across the whole picture rather than in one corner of it: “UV light is implicated in all significant aspects of rosacea: skin inflammation, neoangiogenesis, telangiectasia, and fibrosis, and may even initiate rosacea.”[1]

Two conditions on that, both from the paper itself. It is a narrative review rather than a systematic one, and the authors searched PubMed from January 1990 to November 2020 in English, Spanish and French.[1] So it is a considered summary of a field, gathered up to late 2020, not a pooled measurement of it.

The evidence behind Korean sunscreen for rosacea is thinner than the advice

Here’s the sentence that set the shape of this article. Reporting on what sunscreen does for people with rosacea, the review states plainly: “We found 6 original articles about the impact of sunscreens on rosacea.”[1]

Six. Not six trials of one product, and not six trials of Korean formulas specifically. Six original articles on the whole question of sunscreen in rosacea, gathered from a search running to November 2020. The authors say it again in the conclusion, and they aren’t hedging: “While the use of sunscreens is widely recommended, the literature on the impact of photoprotection in rosacea is scarce.”[1]

They’re also not all the same kind of study. Immediately after the count, the review summarizes one open-label sunscreen study, and then a clinical trial comparing a sodium sulfacetamide and sulfur formulation against metronidazole cream.[1] A single-arm tolerability study and a trial measured against a prescription cream answer very different questions, so “six studies” is a smaller body of evidence than the number alone suggests.

Opening one of the six

The review describes one of the six as “a recent open-label study using a novel water-based sunscreen SPF 50+ containing two emollients” that “found significantly less erythema, dryness, and scaling after 21 days of use.”[1] Its abstract sets out the design in enough detail to judge it.[2] Here is what that says.

Design“This was an open-label, single-center study.”[2] No control group.
Size“The study enrolled 44 individuals (mean age 58.8 years, 91% female).”[2]
LengthApplied once daily to the face for 21 days.[2]
Funding“All authors are employees of Galderma SA. Galderma SA funded the study, and is the producer and developer of Daylong Extreme SPF 50+.”[2]

The results are genuinely encouraging in places. After 21 days the dermatologist recorded significantly less erythema, dryness and scaling, and the participants reported less tension, dryness and tickling.[2] That’s a real finding and we aren’t waving it away.

It’s also not uniformly positive, which is the part that tends to get compressed out. In the same sentence reporting those improvements, the paper records “three cases of pustules and two cases of papules” at day 22, against four cases of pustules and one case of papules at baseline.[2] Pustules went down by one. Papules went up by one. The paper also notes that “some subjects noted itching and burning before and after using the product,” and that one subject developed papules during treatment.[2]

The authors’ own conclusion is careful, and worth reading as written. The product “was well tolerated in rosacea-prone subjects, producing objective and subjective improvements in skin status and symptoms.”[2] Well tolerated is a claim about comfort, not a claim that a sunscreen treats rosacea. With no control arm and 21 days, it couldn’t be the second thing.

We should be even-handed and note that the review has an interest too. Of its four authors, one reported no conflict, one is a consultant for the sunscreen company ISDIN, and two are ISDIN employees, with ISDIN financing the publication expenses.[1] That doesn’t make either paper wrong. It does mean the two most useful documents on this topic were both paid for by companies that sell sunscreen, which is worth knowing before anyone quotes them at you as neutral.

What the review actually says about mineral filters

Plenty of pages treat mineral filters as the settled answer for rosacea. The review is more specific than that, and the specificity matters.

It does report that “some authors recommend sunscreens containing physical or mineral filters with zinc oxide and/or titanium dioxide.”[1] Read the verb. It’s describing what some authors recommend, not presenting a measured comparison against organic filters. The sentence immediately before it settles the comparison question: “Studies comparing the effects of different sunscreens on rosacea are lacking.”[1]

The review does say something about how those formulas feel, and we should quote that too rather than leave it out. Immediately after the recommendation it notes: “These physical sunscreens are usually well-tolerated, although patient adherence can be low, because some can leave a white layer on the skin after application.”[1] Usually well-tolerated is the closest the review comes to the claim that mineral filters suit rosacea better, and it arrives with two qualifiers attached. It is a tolerability observation, not a comparison, and the review has just told us the comparisons have not been done.

Where zinc oxide and titanium dioxide do appear with evidence attached, it is for a different job. The review states that “tinted sunscreens using different concentrations of iron oxide, pigmentary titanium dioxide, and/or zinc oxide have shown to be effective in protecting against visible light.”[1] Visible light, not UV. That’s a real and useful point, and it answers a narrower question than the one the product rankings are answering.

What the review associates with improved symptoms is the rest of the formula. It reports that “the use of sunscreens containing ingredients with emollient, anti-inflammatory, and/or vasoregulatory properties was shown to significantly improve symptomatology.”[1] Emollient, anti-inflammatory, vasoregulatory. Those describe what surrounds the filters, not which filters were chosen.

Its closing suggestion keeps the same register. Adequately formulated sunscreens “could not only provide the required level of photoprotection, but may also help to mitigate the barrier dysfunction, neutralize facial redness (tinted sunscreens), and decrease inflammation and vascular dysfunction.”[1] Note the verbs. Could, and may. That’s the strength of claim the evidence carries.

What that leaves you with

The honest translation is narrow, and it’s mostly about comfort and consistency rather than about picking a winner.

  • Something you can wear daily without discomfort beats a better formula you avoid.
  • Moisturizing and soothing ingredients alongside the filters are the part the review ties to improved symptoms.
  • A tinted formula is worth considering if visible redness is what bothers you, since that’s the effect the review names directly.
  • Filter class isn’t the deciding variable these papers point to, whatever the rankings imply.
  • Where the review does give a number, it gives it plainly, and the two sentences are worth quoting whole: “Strict sun protection is the cornerstone of management of rosacea. Daily use of a very high-tolerance broad-spectrum sunscreen with a minimum SPF of 30 is necessary.”[1]

For the ingredient-level detail behind those choices we have separate write-ups on fragrance-free formulas, on mineral filters, and on what tone-up and tinted formulas do. Our sensitive and acne-prone roundup is the nearest thing we have to picks, and it carries one question on redness and rosacea-prone skin. Read it as a starting point for sensitivity rather than as guidance for a diagnosis, because it was not built against this literature.

One more distinction, because it’s easy to blur. Stinging or breaking out after a sunscreen isn’t automatically rosacea, and rosacea isn’t the only reason a face reacts. We separate those in our piece on irritation versus allergy, and eye-area stinging has its own write-up.

What we’re not saying

Three limits, stated plainly.

  • We aren’t diagnosing anything. Facial redness has a long list of causes, and telling them apart is clinical work. If your face is persistently red, flushing, or developing bumps, that belongs with a dermatologist, not with a shopping page.
  • We aren’t going further than the count allows. The review is more forward here than we are. It calls strict sun protection the cornerstone of management of rosacea, and its conclusion says “the appropriate skin care, use of moisturizers, and adequately formulated sunscreens are the cornerstone of treatment.”[1] We’re staying narrower than that on purpose, because the body of work standing behind those words is six original articles, and because deciding what to do about a diagnosis belongs with a clinician rather than with us.
  • We aren’t saying skip it. Thin evidence about which sunscreen is not the same as evidence against sunscreen, and the UV half of this literature is the part that holds up. If you already have a formula you can wear every day without your skin protesting, the reasonable read is to keep wearing it.

FAQ

Is mineral sunscreen better for rosacea?

The 2021 review does not present a comparison that would settle it. It notes that some authors recommend zinc oxide and titanium dioxide formulas, and it credits tinted formulations containing those pigments with protecting against visible light.[1] What it ties to improved symptoms is sunscreens carrying emollient, anti-inflammatory or vasoregulatory ingredients, which is a statement about the rest of the formula.[1] Many people with rosacea do prefer mineral formulas, and that preference is fine. It’s just not what these papers demonstrate.

How many studies are there on sunscreen and rosacea?

The 2021 review reports finding six original articles on the impact of sunscreens on rosacea, and describes the photoprotection literature in rosacea as scarce.[1] Its search covered PubMed from January 1990 to November 2020, in English, Spanish and French, so anything published since then sits outside that count.[1]

Does a tinted sunscreen help with redness?

The review credits tinted sunscreens containing iron oxide, pigmentary titanium dioxide and zinc oxide with protection against visible light, and lists neutralizing facial redness among the things well formulated sunscreens may do.[1] The redness point is phrased as a possibility rather than a demonstrated outcome, and it’s a cosmetic effect, meaning it addresses how redness looks rather than the underlying condition.

Why does everyone recommend sunscreen for rosacea if the evidence is thin?

Because the two questions are different. That UV is involved in rosacea is described consistently across this literature.[1] Which sunscreen performs best in rosacea is the question with six original articles behind it as of late 2020. Broad advice to protect from the sun rests on the first question, and product rankings borrow authority from it.

Sources

Method, so you can check us. The 2021 review is open access and we read the full text through PubMed Central. For the 2017 study we read the abstract in full through the PubMed E-utilities interface and did not open the publisher’s full text, so every figure quoted from it below is one the abstract states. Conflict of interest statements are quoted as printed by the journals. Both were read on 2026-08-11.

  1. Morgado-Carrasco D, Granger C, Trullas C, Piquero-Casals J. “Impact of ultraviolet radiation and exposome on rosacea: Key role of photoprotection in optimizing treatment.” Journal of Cosmetic Dermatology, 2021 Nov;20(11):3415-3421, doi 10.1111/jocd.14020, PMID 33626227, PMCID PMC8596706. Full text read. Source for the multi-factorial description, for the pro-inflammatory, pro-angiogenic and pro-fibrotic finding, for the count of six original articles, for the scarce literature statement, for the description of the open-label study and the sodium sulfacetamide comparison, for the physical and mineral filter recommendation, for the tinted sunscreen and visible light statements, for the emollient, anti-inflammatory and vasoregulatory point, for the note that physical sunscreens are usually well tolerated with the adherence and white layer caveats, for the strict sun protection and minimum SPF 30 statements, for the conclusion on skin care, moisturizers and adequately formulated sunscreens, and for the review design and search dates. Conflict of interest as printed: one author reported none, one is a consultant for ISDIN, two are ISDIN employees, and ISDIN financed the publication expenses. https://pubmed.ncbi.nlm.nih.gov/33626227/
  2. Grivet-Seyve M, Santoro F, Lachmann N. “Evaluation of a novel very high sun-protection-factor moisturizer in adults with rosacea-prone sensitive skin.” Clinical, Cosmetic and Investigational Dermatology, 2017 Jun 10;10:211-219, doi 10.2147/CCID.S134857, PMID 28652793. Abstract read in full. Source for the open-label single-center design, for the 44 participants and their mean age, for the 21 day application period, for the erythema, dryness and scaling results, for the pustule and papule counts at baseline and day 22, for the itching and burning note, and for the tolerability conclusion. Conflict of interest as printed: all authors are employees of Galderma SA, which funded the study and produces the tested product. https://pubmed.ncbi.nlm.nih.gov/28652793/

Topics: · · · · All topics

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *